APA (7th ed.) Citation

R, A., G, A., Y, J., V, F., N, M., S, A., & R, F. (2025). CCN3/NOV Serum Levels in Non-alcoholic Fatty Liver Disease (NAFLD) Patients in Comparison with the Healthy Group and its Correlation with TNF-α and IL-6. Current molecular medicine, 25(5), 605. https://doi.org/10.2174/0115665240285539240214111947

Chicago Style (17th ed.) Citation

R, Afrisham, Alasvand G, Jadidi Y, Farrokhi V, Moradi N, Alizadeh S, and Fadaei R. "CCN3/NOV Serum Levels in Non-alcoholic Fatty Liver Disease (NAFLD) Patients in Comparison with the Healthy Group and Its Correlation with TNF-α and IL-6." Current Molecular Medicine 25, no. 5 (2025): 605. https://doi.org/10.2174/0115665240285539240214111947.

MLA (9th ed.) Citation

R, Afrisham, et al. "CCN3/NOV Serum Levels in Non-alcoholic Fatty Liver Disease (NAFLD) Patients in Comparison with the Healthy Group and Its Correlation with TNF-α and IL-6." Current Molecular Medicine, vol. 25, no. 5, 2025, p. 605, https://doi.org/10.2174/0115665240285539240214111947.